American Healthcare REIT, Inc. (NYSE: AHR) witnessed a significant insider transaction on December 23, 2023, as Director Jeffrey Hanson sold 19,208 shares of the company’s stock. The shares were sold at an average price of $48.40, culminating in a total transaction value of $929,667.20. This sale was officially reported in a filing with the U.S. Securities and Exchange Commission (SEC).
Stock Performance and Market Position
Following the sale, shares of American Healthcare REIT opened at $47.02 on Thursday. The company currently holds a market capitalization of $8.32 billion. Its price-to-earnings (P/E) ratio stands at 335.86, while the price-to-earnings-growth (PEG) ratio is 1.99. Additionally, the stock has a beta of 0.93, indicating moderate volatility compared to the market.
American Healthcare REIT has fluctuated notably over the past year, with a low of $26.40 and a high of $51.01. The firm’s moving averages reflect stability, with a 50-day moving average of $47.99 and a 200-day moving average of $42.76.
Dividend Announcement and Analyst Insights
In addition to insider trading activities, American Healthcare REIT announced a quarterly dividend of $0.25 per share, scheduled for payment on January 16, 2024. Shareholders on record as of December 31, 2023, will be eligible for this dividend, which translates to an annualized yield of 2.1%. Notably, the company’s dividend payout ratio (DPR) currently stands at an unusual 714.29%, indicating a high proportion of earnings distributed as dividends.
Analysts have recently given mixed to positive reviews of American Healthcare REIT. Citizens JMP raised their price target from $50.00 to $60.00, rating the stock as “market outperform.” Similarly, Truist Financial increased its target from $46.00 to $53.00 with a “buy” recommendation. Other notable upgrades include a boost from Citigroup, which raised its target to $52.00 and designated the stock as “neutral.”
According to data from MarketBeat.com, American Healthcare REIT holds an overall average rating of “Buy” with a consensus target price of $51.64. The stock has attracted attention from analysts, with two ranking it as a “Strong Buy,” ten as “Buy,” and two as “Hold.”
American Healthcare REIT, Inc. is a publicly traded real estate investment trust specializing in the acquisition, ownership, and management of healthcare-related properties across the United States. Its portfolio encompasses senior housing communities, skilled nursing facilities, medical office buildings, and outpatient care centers, all structured under long-term net lease or triple-net lease agreements. This approach aims to provide stable rental income while addressing the increasing demand for healthcare services driven by demographic trends.
As the company continues to navigate the evolving healthcare landscape, its strategic focus on partnering with established healthcare operators positions it well for future growth.
